Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Bristol Myers Squibb (BMY) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareBMY

Latest price · Nov 20, 2026 $59.12 +1.3% on the day · +34.4% over 12 months 52-week range $43.98 – $67.39
Get BMY alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling4last 12 months
Reported sales$2.5M2 of 5 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Jan 28, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Julia A. Haller, Director sold 3,800 shares at $63.31 ($241K).

Trade date
Nov 5, 2026
Disclosed to the SEC
Nov 6, 2026
Type
Sale (code S)

Read the original SEC filing ↗All BMY insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

BMY insider transactions (Form 4)

Open-market purchases and sales. 145 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Nov 6SEC Julia A. HallerDirector Sell 3,80030,279 held (−11%) $63.31 $241K -6.6% —
Sep 10SEC Cristian MassacesiEvp,Chief Med Offr,Head Of Dev Sell 6,24918,748 held (−25%) $64.57 $403K -8.4% —
Aug 26SEC Phil M. HolzerSvp And Controller Sell 50016,862 held (−3%) $67.50 $34K -12.4% —
Apr 2SEC David V. ElkinsCFO Sell Plan 25,519163,729 held (−13%) $61.60 $1.6M -4.0% —
Apr 2SEC David V. ElkinsCFO Sell Plan 4,481159,248 held (−3%) $62.05 $278K -4.7% —
Historical context

Similar past setups: not applicable. BMY has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with BMY in the Research Lab

BMY has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

BMY closeInsider buyInsider sale
40506070DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-05EEarnings release filed 2026-04-30EEarnings release filed 2026-07-30EEarnings release filed 2026-10-29Sold $33,750 on 2026-08-25 · Phil M. HolzerSold $240,578 on 2026-11-05 · Julia A. HallerSold $403,498 on 2026-09-09 · Cristian MassacesiSold $1,850,016 on 2026-04-01 · David V. Elkins
Bought, 12 months$0
Sold, 12 months$2.5M
Insiders buying0
Insiders selling4

Bristol Myers Squibb insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $2.5M of BMY stock on the open market; P/E 17.2 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

BMY insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $1.9M sold (2 trades)Q2 2026Q3 2026: $437K sold (2 trades)Q3 2026Q4 2026: $241K sold (1 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$241K1
Q3 2026—0$437K2
Q2 2026—0$1.9M2

Valuation, profit and volume

P/E (trailing)17.2Sector median 25.0
Volume vs. 50-day0.9×Last 5 sessions

Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Bristol Myers Squibb insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $2.5M. 2 of 5 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

BMY earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Oct 29, 2026 +6.9% None +3.2%S&P -2.1% pending
Jul 30, 2026 +10.8% None +3.5%S&P +2.4% +1.9%
Apr 30, 2026 -0.8% Sold $1.9M +1.1%S&P +1.3% -1.8%
Feb 5, 2026 +6.3% None +7.6%S&P +0.6% -2.7%
Oct 30, 2025 -2.7% None +8.1%S&P -0.8% +6.8%
Jul 31, 2025 -1.0% None -3.8%S&P -2.0% +6.7%
Apr 24, 2025 -8.6% None -1.3%S&P +2.8% -2.2%
Feb 6, 2025 +4.7% None -4.8%S&P -0.6% +7.5%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

BMY short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 65% of volume sold short2026-08-27: 51% of volume sold short2026-08-28: 55% of volume sold short2026-08-31: 56% of volume sold short2026-09-01: 50% of volume sold short2026-09-02: 56% of volume sold short2026-09-03: 54% of volume sold short2026-09-04: 58% of volume sold short2026-09-08: 60% of volume sold short2026-09-09: 53% of volume sold short2026-09-10: 54% of volume sold short2026-09-11: 52% of volume sold short2026-09-14: 55% of volume sold short2026-09-15: 57% of volume sold short2026-09-16: 49% of volume sold short2026-09-17: 44% of volume sold short2026-09-18: 75% of volume sold short2026-09-21: 52% of volume sold short2026-09-22: 46% of volume sold short2026-09-23: 40% of volume sold short2026-09-24: 35% of volume sold short2026-09-25: 28% of volume sold short2026-09-28: 30% of volume sold short2026-09-29: 63% of volume sold short2026-09-30: 67% of volume sold short2026-10-01: 53% of volume sold short2026-10-02: 39% of volume sold short2026-10-05: 42% of volume sold short2026-10-06: 31% of volume sold short2026-10-07: 46% of volume sold short2026-10-08: 29% of volume sold short2026-10-09: 29% of volume sold short2026-10-12: 52% of volume sold short2026-10-13: 43% of volume sold short2026-10-14: 44% of volume sold short2026-10-15: 39% of volume sold short2026-10-16: 36% of volume sold short2026-10-19: 37% of volume sold short2026-10-20: 60% of volume sold short2026-10-21: 51% of volume sold short2026-10-22: 51% of volume sold short2026-10-23: 58% of volume sold short2026-10-26: 52% of volume sold short2026-10-27: 59% of volume sold short2026-10-28: 57% of volume sold short2026-10-29: 45% of volume sold short2026-10-30: 49% of volume sold short2026-11-02: 32% of volume sold short2026-11-03: 30% of volume sold short2026-11-04: 26% of volume sold short2026-11-05: 47% of volume sold short2026-11-06: 51% of volume sold short2026-11-09: 45% of volume sold short2026-11-10: 52% of volume sold short2026-11-11: 53% of volume sold short2026-11-12: 45% of volume sold short2026-11-13: 53% of volume sold short2026-11-16: 55% of volume sold short2026-11-17: 32% of volume sold short2026-11-18: 50% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 50%20-day average: 45%Prior 2 months: 47%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded BMY

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Thomas H TubervilleSenate Sold $1,001 - $15,000 Apr 15, 2025Aug 5, 2026 +26.9%
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +4.3%

Insiders at Bristol Myers Squibb

InsiderBoughtSoldLast filingPast buys beat S&PScore
David V. ElkinsCFO — $1.9M Apr 2, 2026 — —
Cristian MassacesiEvp,Chief Med Offr,Head Of Dev — $403K Sep 10, 2026 — —
Julia A. HallerDirector — $241K Nov 6, 2026 — —
Phil M. HolzerSvp And Controller — $34K Aug 26, 2026 — —
Adam LenkowskyEvp, Chief Commercial Officer — — Nov 4, 2026 — —
Karin ShanahanEvp, Chief Supply Chain & Ops — — Nov 3, 2026 — —
Gregory Scott MeyersEvp, Chief Digital & Tech Off. — — Nov 3, 2026 — —
Christopher S. BoernerCEO — — Nov 3, 2026 0 of 3 —
Cari GallmanGeneral Counsel — — Oct 5, 2026 — —
Bartie Wendy ShortEvp, Corporate Affairs — — Sep 3, 2026 — —
Robert M. PlengeEvp, Chief Research Officer — — Mar 12, 2026 — —
Ahn Amanda PooleEvp, Chief People Officer — — Mar 12, 2026 — —
Lynelle HochPresident — — Mar 12, 2026 — —
Benjamin HickeyPresident — — Mar 3, 2026 — —

Board links: companies that share insiders with BMY

Directors and executives who filed Form 4s for BMY and another company in the last 12 months.

See the map →
  • CLColgate-Palmolive Christopher S. Boerner CEO here · Director at CL · latest filing Nov 3, 2026
  • TPRTapestry David V. Elkins CFO here · Director at TPR · latest filing Nov 12, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

BMY stock: common questions

Are Bristol Myers Squibb insiders buying BMY stock?

No. No Bristol Myers Squibb insider reported an open-market purchase of BMY in the past 12 months.

Are Bristol Myers Squibb insiders selling BMY stock?

4 insiders reported sales worth $2.5M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is BMY's P/E ratio?

BMY trades at about 17.2 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is BMY's 52-week range?

Over the past year BMY has traded between $43.98 and $67.39. It last closed at $59.12 on Nov 20, 2026.